Synergy Pharmaceuticals Inc Fl (NASDAQ:SGYP)

CAPS Rating: 2 out of 5 27.31

SGYP News and Commentary

Caps

How do you think SGYP will perform against the market?

Add Stock to CAPS Watchlist

All Players

69 Outperform
45 Underperform
 

All-Star Players

16 Outperform
18 Underperform
 

Wall Street

2 Outperform
1 Underperform
 

Top SGYP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

usubanas (99.80)
Submitted August 03, 2015

Good results in CIC bode well for good results in IBS-C later this year

DarthMaul09 (29.09)
Submitted October 14, 2009

Synergy Pharmaceuticals, Inc. (Synergy) is a development-stage biopharmaceutical company. The Company primarily focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Synergy’s lead drug candidates, acquired from… More

SGYP VS S&P 500 (SPY)

Fools bearish on SGYP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SGYP.

Recs

0
Member Avatar SmartAce (99.94) Submitted: 11/14/2017 2:05:10 PM : Underperform Start Price: $2.17 SGYP Score: +14.27

His last words were, "I'm just going to tell her to calm down, and remind her that she still hasn't made dinner."

Recs

0
Member Avatar DADDYBLAME (65.88) Submitted: 6/21/2017 5:11:36 PM : Outperform Start Price: $5.43 SGYP Score: -82.29

A number of investors have sunk significant amounts of capital in this pharma in recent months. I wasn't initially sure if this stock was being day traded as in the past, but after some prelim due dilligence on my part I actually invested real money in this company @ $4.50 per share, just checking the waters with a toe and not belly floppin. Price estimates have been updated higher, their only FDA approved drug for constipation has been growing steadily since March of this year and this same drug is in clinical trials for use in treating IBS-C with prelim results promising. In addition they have not partnered with any of the big Pharma companies which says to me that although risky as well as extremely expensive to market any new drug, they are confident in its future worth. All said, I takes my chances and roll the dice with reduced odds as any real "craps" player does before laying down any money. Still I advise caution to those with rsk adverse natures to stay away and sleep at night. Time will tell whether I'm right or just delusional.

Recs

0
Member Avatar genedom (92.29) Submitted: 8/3/2016 4:06:38 PM : Outperform Start Price: $4.18 SGYP Score: -76.64

A takeover target after FDA approval in early 2017.

Leaderboard

Find the members with the highest scoring picks in SGYP.

Score Leader

hateninja

hateninja (< 20) Score: +234.46

The Score Leader is the player with the highest score across all their picks in SGYP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
hateninja < 20 6/7/2010 Underperform 3Y $11.00 -82.45% +152.00% +234.46 0 Comment
SirCharms < 20 6/25/2009 Underperform 5Y $2.95 -34.58% +197.69% +232.26 0 Comment
dlwaz < 20 6/9/2010 Underperform 1Y $11.00 -82.45% +147.72% +230.18 0 Comment
JGus 28.22 6/4/2010 Underperform 5Y $10.25 -81.17% +147.61% +228.78 0 Comment
BuffetsMentor 27.25 6/7/2010 Underperform 5Y $9.10 -78.79% +147.82% +226.61 0 Comment
DDD424 < 20 6/3/2010 Underperform 1Y $10.65 -81.88% +140.61% +222.49 0 Comment
MicroCaptain < 20 2/4/2010 Underperform 1Y $6.25 -69.12% +143.77% +212.89 0 Comment
longtermgrowth09 < 20 1/27/2010 Underperform 5Y $5.90 -67.29% +143.35% +210.63 0 Comment
brocksamson 28.37 8/4/2009 Underperform 5Y $3.05 -36.72% +170.15% +206.87 0 Comment
stockjock11 < 20 3/31/2010 Underperform NS $8.45 -77.16% +126.83% +203.99 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 85.10 6/8/2016 Underperform 3W $4.11 -53.04% +25.09% +78.13 0 Comment
TrackCitigroup 92.97 6/17/2013 Outperform NS $4.99 -61.32% +61.70% -123.02 0 Comment
TrackCantorFitz < 20 4/9/2013 Outperform NS $6.41 -69.89% +69.75% -139.64 0 Comment
TrackZacks < 20 9/17/2012 Underperform 3M $4.66 -34.12% -5.58% +28.54 11/12/2012 @ $3.07 1 Comment

Featured Broker Partners